(SLE)
ALSEVALIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS VTCN1 (V-SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1, B7-H4, B7H4)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-450) [VH (HOMO SAPIENS IGHV4-39*01 (96.0%) -(IGHD) -IGHJ5*02 (93.8%)) CDR-IMGT [10.7.12] (26-35.53-59.98-109) (1-120) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 (CH1 K120 (217) (121- 218), HINGE 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-214')- DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') [VKAPPA (HOMO SAPIENS IGKV3-15*01 (96.8%) -IGKJ4*01 (91.7%)) CDR-IMGT [6.3.9] (27-32.50-52.89-97) (1'-107') - HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO-FUT8-/-) CELLS, GLYCOFORM ALFA. PROPOSED INN: LIST 122(WHO)
ALSEVALIMABUM(INN)